Free Trial

Resverlogix (RVX) Competitors

Resverlogix logo
C$0.04 0.00 (0.00%)
As of 05/22/2025 11:10 AM Eastern

RVX vs. AEZS, GSD, LTY, ACST, REUN, NEPT, ATE, SBM, HEM, and IMV

Should you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Aeterna Zentaris (AEZS), Devonian Health Group (GSD), Liberty Biopharma (LTY), Acasti Pharma (ACST), Reunion Neuroscience (REUN), Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), Sirona Biochem (SBM), Hemostemix (HEM), and IMV (IMV). These companies are all part of the "biotechnology" industry.

Resverlogix vs.

Resverlogix (TSE:RVX) and Aeterna Zentaris (TSE:AEZS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations.

5.2% of Aeterna Zentaris shares are held by institutional investors. 42.7% of Resverlogix shares are held by insiders. Comparatively, 1.3% of Aeterna Zentaris shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Resverlogix has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Aeterna Zentaris has a beta of 2.26, suggesting that its stock price is 126% more volatile than the S&P 500.

Resverlogix received 302 more outperform votes than Aeterna Zentaris when rated by MarketBeat users. However, 88.89% of users gave Aeterna Zentaris an outperform vote while only 84.01% of users gave Resverlogix an outperform vote.

CompanyUnderperformOutperform
ResverlogixOutperform Votes
310
84.01%
Underperform Votes
59
15.99%
Aeterna ZentarisOutperform Votes
8
88.89%
Underperform Votes
1
11.11%

Resverlogix has higher earnings, but lower revenue than Aeterna Zentaris. Resverlogix is trading at a lower price-to-earnings ratio than Aeterna Zentaris, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ResverlogixN/AN/A-C$2.81M-C$0.02-1.98
Aeterna ZentarisC$2.37M0.00-C$18.05M-C$3.18N/A

Resverlogix's return on equity of 6.06% beat Aeterna Zentaris' return on equity.

Company Net Margins Return on Equity Return on Assets
ResverlogixN/A 6.06% -34.90%
Aeterna Zentaris N/A -81.71%-29.96%

In the previous week, Resverlogix's average media sentiment score of 0.00 equaled Aeterna Zentaris'average media sentiment score.

Company Overall Sentiment
Resverlogix Neutral
Aeterna Zentaris Neutral

Summary

Resverlogix beats Aeterna Zentaris on 6 of the 11 factors compared between the two stocks.

Get Resverlogix News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVX vs. The Competition

MetricResverlogixBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$7.92MC$129.18MC$5.33BC$5.94B
Dividend Yield7.02%3.74%5.21%6.32%
P/E Ratio-1.983.4226.7729.92
Price / SalesN/A4,222.28393.27823.31
Price / Cash132.5013.1938.2583.71
Price / Book-0.1733.156.773.99
Net Income-C$2.81M-C$91.56MC$3.23BC$301.32M
7 Day PerformanceN/A2.84%0.43%0.43%
1 Month PerformanceN/A7.54%9.07%6.45%
1 Year PerformanceN/A100.95%18.57%17.05%

Resverlogix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVX
Resverlogix
N/AC$0.04
flat
N/A-27.3%C$7.92MN/A-1.9819
AEZS
Aeterna Zentaris
N/AN/AN/AN/AC$25.37MC$2.37M-2.6120
GSD
Devonian Health Group
N/AC$0.16
+3.2%
N/A-17.9%C$23.72MC$9.75M-8.006Gap Up
LTY
Liberty Biopharma
N/AC$2.00
+∞
N/A+0.0%C$21.54MN/A-12.66N/AGap Up
ACST
Acasti Pharma
N/AC$0.58
+1.8%
N/A+0.0%C$18.19MC$2.71M-1.2132
REUN
Reunion Neuroscience
N/AN/AN/AN/AC$16.64MC$4.86M-0.43190Gap Down
NEPT
Neptune Wellness Solutions
N/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap Down
ATE
Antibe Therapeutics
N/AN/AN/AN/AC$15.64MC$9.71M-0.8411
SBM
Sirona Biochem
N/AC$0.06
-7.7%
N/A+0.0%C$15.41MC$683,768.00-6.00N/AGap Down
High Trading Volume
HEM
Hemostemix
N/AC$0.10
flat
N/A+175.0%C$13.84MN/A-2.77N/AGap Down
IMV
IMV
N/AN/AN/AN/AC$13.12MC$23,000.00-0.1820

Related Companies and Tools


This page (TSE:RVX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners